Inviragen Obtains $5,454,000 New Round

  • Feed Type
  • Date
    3/31/2012
  • Company Name
    Inviragen
  • Mailing Address
    1613 Prospect Pkwy. Fort Collins, CO 80525
  • Company Description
    Inviragen, Inc. is committed to developing safe, effective vaccines to address this need. Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide.
  • Website
    http://www.inviragen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,454,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Charter Life Sciences Fund
  • Venture Investor
    Venture Investors
  • Venture Investor
    Bio*One Capital Pte